The obtained activity scores should reflect the relative activity of AKT signaling in the breast cancer cell lines, and thus we posited that the drug sensitivity values correlating most strongly with the activity scores would be those of PI3K/AKT/mTOR inhibitors. This evidence concerns the gene PIK3CG and breast cancer.